ProGnosis Biotech is delighted to announce the opening of our subsidiary in Italy, further expanding our global presence. This exciting development enables us to better serve the Italian market in the areas of food, beverage, agriculture, and clinical diagnostics with our advanced in-vitro testing devices. Italy, offers an excellent opportunity for us to provide tailored solutions and contribute to enhanced safety and quality control.
This addition joins our existing subsidiaries in Serbia, Poland, and France, reinforcing our commitment to delivering exceptional service and support in the region. These strategic locations have played a key role in establishing strong partnerships, gaining valuable market insights, and customizing our offerings to meet the unique requirements of each region.
As a global leader, ProGnosis Biotech is committed to revolutionizing testing methods, setting industry standards, and making a positive impact in the markets we serve. We look forward to collaborating with our Italian customers and building a safer and healthier future together.
To learn more about ProGnosis Biotech and our wide range of testing devices, please visit our website or reach out to our dedicated team. We are here to provide you with the information and assistance you need.
